Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Direct head-to-head comparisons between CJC-1295, Sermorelin, Ipamorelin, Tesamorelin, GHRP-2, GHRP-6, Hexarelin, and MK-677 are limited
Semax is an ACTH-derived neuropeptide studied primarily in the context of cognition, attention, and neuroprotection
Nitric oxide-induced blockade of NMDA receptors
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
In animal models and in-vitro studies, this peptide has been observed to interact with the Nitric Oxide (NO) system and VEGF (Vascular Endothelial Growth Factor) pathways
US$ 26.89
US$ 26.22
US$ 29.70
US$ 29.44
US$ 23.53
US$ 25.59
